Cancer Genetics and Epigenetics 2024, Vol.12, No.3, 157-165 http://medscipublisher.com/index.php/cge 165 Dhanda S.K., Mahajan S., and Manoharan M., 2023, Neoepitopes prediction strategies: an integration of cancer genomics and immunoinformatics approaches, Briefings in Functional Genomics, 22(1): 1-8. https://doi.org/10.1093/bfgp/elac041 PMid:36398967 Gao M., Yang T.T., Li G.L., Chen R., Liu H.C, Gao Q., Wan K.L., and Feng S.D.,2020, Analysis on drug resistance-associated mutations of multi-drug resistant Mycobacterium tuberculosis based on whole-genome sequencing in China, Zhonghua Liuxingbingxue Zazhi (Chinese Journal of Epidemiology), 41(5): 770-775. Harrison P.T., Vyse S., and Huang P.H., 2020, Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer, In Seminars in Cancer Biology, 61: 167-179. https://doi.org/10.1016/j.semcancer.2019.09.015 PMid:31562956 PMCid:PMC7083237 Hodge R.G., Schaefer A., Howard S.V., and Der C.J., 2020, RAS and RHO family GTPase mutations in cancer: twin sons of different mothers?, Critical Reviews in Biochemistry and Molecular Biology, 55(4): 386-407. https://doi.org/10.1080/10409238.2020.1810622 PMid:32838579 Liu Z.C., Li Z.X., Zhang Y., Zhou T., Zhang J.Y., You W.C., Pan K.f., and Li W.Q., 2021, Journal of interpretation on the report of global cancer statistics 2020, Zhongliu Zonghe Zhiliao Dianzi Zazhi (Multidisciplinary Cancer Management (Electronic Version)), 7(2): 1-13. Mattiuzzi C., and Lippi G., 2019, Current cancer epidemiology, Journal of Epidemiology and Global Health, 9(4): 217. https://doi.org/10.2991/jegh.k.191008.001 PMid:31854162 PMCid:PMC7310786 Wu A.S., Liu X.N., Liu Y.H., Liu G., and Liu L., 2019, Application of second generation gene sequencing data management and big data platform in precision medicine, Zhongguo Shengwu Gongcheng Zazhi (China Biotechnology), 39(2): 101-111. Yin Q., Guo T., Zhou Y., Sun L., Meng M., Ma L., and Wang X., 2022, Effectiveness of alectinib and osimertinib in a brain metastasized lung adenocarcinoma patient with concurrent EGFR mutations and DCTN1‐ALK fusion, Thoracic Cancer, 13(4): 637-642. https://doi.org/10.1111/1759-7714.14291 PMid:34964276 PMCid:PMC8841708 Zhao X.M., Zhang Y.X., Ma T.H., and Hu Y.F., 2023, Advances in cancer diagnosis and treatment based on NGS technology, Yaoxue Jinzhan (Progress in Pharmaceutical Sciences), 47(6): 404-416.
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==